GLP-1 Telehealth for Adults Over 50: What's Different

If you're over 50 and considering GLP-1 medication through telehealth, the clinical picture is different — and the stakes are higher — than for a 30-year-old. Muscle preservation matters more. Bone density is already declining. Kidney function may be reduced. Drug interactions are more likely. And the benefits of weight loss for cardiovascular health and metabolic disease may be more immediately relevant. Here's what older adults need to know specifically about GLP-1 telehealth.

The Muscle Loss Risk Is Amplified

After age 30, adults lose approximately 3–8% of muscle mass per decade — a process called sarcopenia. GLP-1 medications accelerate this natural decline because the significant caloric reduction (24–39% less intake) affects muscle tissue as well as fat. For a 55-year-old, losing 20 pounds of muscle along with 30 pounds of fat can mean the difference between independence and disability in later decades.

This doesn't mean older adults shouldn't take GLP-1 medications — the cardiovascular and metabolic benefits of weight loss may outweigh the lean mass risk. But it means the protein and resistance exercise recommendations aren't optional at this age. They're essential.

Protein targets: 1.2–1.6 grams per kilogram of body weight daily, which is higher than the standard recommendation. For a 180-pound adult, that's 100–130 grams of protein per day. This is challenging when appetite is suppressed — protein shakes and protein-fortified foods become necessary tools.

Resistance training: At minimum 2–3 sessions per week targeting major muscle groups. For adults over 50 new to resistance training, starting with a physical therapist or certified personal trainer who understands age-related considerations is worth the investment.

Kidney and Liver Considerations

Kidney function naturally declines with age. GLP-1 medications can cause dehydration through reduced fluid intake and gastrointestinal side effects, which can stress already-compromised kidneys. Baseline kidney function tests (BUN, creatinine, eGFR) are essential before starting, and periodic monitoring is more important for older adults than younger patients.

Similarly, liver function may be affected by GLP-1 medications. Many adults over 50 already have some degree of fatty liver disease (MASLD, formerly NAFLD), which GLP-1 medications may actually improve — but baseline liver function tests establish a monitoring framework.

Drug Interactions

Older adults are more likely to take multiple medications. GLP-1 medications interact with several drug classes that are common in the 50+ population. They can enhance the blood-sugar-lowering effects of sulfonylureas and insulin, increasing hypoglycemia risk. They slow gastric emptying, which can alter the absorption of other oral medications (particularly levothyroxine, birth control pills, and some blood pressure medications).

Your telehealth prescriber should review your complete medication list and adjust timing or dosing of other drugs as needed. If your platform's intake form doesn't ask about all current medications — including over-the-counter and supplements — volunteer the information proactively.

Medicare Coverage in 2026

If you're over 65 and on Medicare, the GLP-1 coverage landscape improved significantly in 2026. The Medicare GLP-1 Bridge program (launching July 1, 2026) provides access to Wegovy, Zepbound KwikPen, and Foundayo for eligible beneficiaries with obesity at a $50/month copay. This is the first time Medicare has covered GLP-1 medications specifically for weight loss.

Eligibility requires a prior authorization submitted by your prescriber. Check with CMS or your Part D plan for specific documentation requirements.

Platforms with Relevant Expertise